TRDAEntrada Therapeutics, Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $13.88 (+0.00% today)

Market Cap: $503.44M

P/E (TTM): -3.80

Analyst Upside: 47.7%

Relative Strength (RS%): 22

1.6% from 52-week high

Back to Scanner

TRDA

NASDAQRS 22Score 43

Entrada Therapeutics, Inc.

HealthcareBiotechnology$503.44M2 setups passing
$13.88
0.0% ($0.00)
+1.6% from 52W High
P/E (TTM)
-3.80
Fwd P/E
PEG
Analyst Upside
+47.7%
EPS Growth
Gross Margin
-54.4%
ROE
-39.8%
D/E
0.17
Div Yield
0.0%
Avg Volume
197.4K

Price Chart

Key Levels

SMA 200
$8.51
SMA 50
$11.78
Price
$13.88
52W High
$13.66
Target
$20.50

Setup Radar

2/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst